Vaccine News and Research

Latest Vaccine News and Research

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Clinical trials for experimental HIV vaccines based on mRNA technology begin in United States

Understanding COVID-19 vaccine hesitancy and decision-making during pregnancy

Understanding COVID-19 vaccine hesitancy and decision-making during pregnancy

Covid and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

Covid and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

Minimal system for SARS-CoV-2 based virus-like particle production to study viral assembly and entry

Minimal system for SARS-CoV-2 based virus-like particle production to study viral assembly and entry

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

The potential efficacy of nasal nanoparticle COVID-19 vaccines

The potential efficacy of nasal nanoparticle COVID-19 vaccines

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

Study investigates whether coinfection with multiple SARS-CoV-2 variants exists in COVID-19 patients

A ferritin nanoparticle candidate vaccine for COVID

A ferritin nanoparticle candidate vaccine for COVID

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

Government provides new guidance for living with COVID

Government provides new guidance for living with COVID

Study provides further assurances about the safety of COVID-19 vaccination during pregnancy

Study provides further assurances about the safety of COVID-19 vaccination during pregnancy

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.